Dermatology Collaboration and Licensing Deals Analysis Report and Directory 2016-2023 –

DUBLIN–(BUSINESS WIRE)–The “Dermatology Collaboration and Licensing Deals 2016-2023” report has been added to’s offering. Fully revised and updated, the report provides details of dermatology deals from 2016 to 2023. Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the worlds leading biopharma companies. The … [Read more…]

CN Bio Wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for Ongoing Research With the FDA

Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN … [Read more…]

U.S. Medical Spas Industry Boosted by the Pandemic –

DUBLIN–(BUSINESS WIRE)–The “U.S. Medical Spas Industry” report from Marketdata LLC has been added to’s offering. This groundbreaking new report examines the booming $17.5 billion business of medical spas. Industry revenues have more than tripled since 2012. There are now 8,800 medical spas operating in the United States – an interesting hybrid niche healthcare/cosmetic facility … [Read more…]

Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats

SENVELGO® (velagliflozin oral solution) is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus SENVELGO® makes treating feline diabetes simple and convenient for both cats and cat owners Up to one in three cats are euthanized within the first year of diagnosis due to previous complex treatments … [Read more…]

Berlin Cures advances fight against Long COVID on a pan-European level

BERLIN–(BUSINESS WIRE)–Berlin Cures, a biotechnology company specialized in neutralizing functional autoantibodies (fAABs), is expanding its Phase II clinical trial into a pan-European, multi-center collaboration in the fight against Long COVID. A total of 12 sites in Germany, Austria, Switzerland, Finland and Spain are working to advance clinical research into this escalating global health problem. Additional … [Read more…]

Domo Announces Winners in Inaugural Higher Education Student Data Case Competition

SILICON SLOPES, Utah–(BUSINESS WIRE)–#highereducation–Today Domo (Nasdaq: DOMO) announced Utah State University students Brigham Cook, Christopher Harris, Oliver Heady and Rylie Swanson as the winners of Domo’s Higher Education Student Case Competition, which included over 35 teams from colleges and universities from across the U.S. The Utah State University students won $30,000 in prizes for developing … [Read more…]

Favorable Safety Results From First Subjects of ANGANY’s New Biologic Against Allergy to Cats, Clinical Study to Move Ahead

QUEBEC CITY–(BUSINESS WIRE)–ANGANY inc. announces that it has received a unanimous recommendation from its Safety Review Committee to press ahead with its First-in-Human study of ANG-101, the company’s innovative cat allergy therapeutic candidate. This clinical study is an open label, single site evaluation of the safety, allergenicity and immunogenicity of this First-in-class biologic. The study … [Read more…]

Durin Technologies, Inc., Appoints CEO

Dr. Mert Sahin to extend expertise to company’s biomarker development and diagnostic commercialization STRATFORD, N.J.–(BUSINESS WIRE)–Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced the appointment of Dr. Mert Sahin as Chief Executive Officer. Dr. Sahin is a highly accomplished business executive with an impressive track record of success … [Read more…]

Broken String Biosciences Appoints Gavin Burns as Vice President of Quality and Operations

Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping platform Expansion to leadership team follows recent appointments of Vincent Smith as Chief Technology Officer, and Jessica Rich, as Vice President of Business Development CAMBRIDGE, England–(BUSINESS WIRE)–Broken String Biosciences (“Broken String”), … [Read more…]

Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at Evercore ISI HealthCONx Conference on November 29, 2023 at 7:55 a.m. … [Read more…]